Parametric Portfolio Associates’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-70,225
| Closed | -$1.26M | – | 4021 |
|
|
2020
Q2 | $1.26M | Sell |
70,225
-6,532
| -9% | -$90.9K | ﹤0.01% | 2791 |
|
|
2020
Q1 | $547K | Sell |
76,757
-14,701
| -16% | -$183K | ﹤0.01% | 3120 |
|
|
2019
Q4 | $2.18M | Buy |
91,458
+21,939
| +32% | +$605K | ﹤0.01% | 2635 |
|
|
2019
Q3 | $1.86M | Sell |
69,519
-8,487
| -11% | -$238K | ﹤0.01% | 2678 |
|
|
2019
Q2 | $2.12M | Buy |
78,006
+10,065
| +15% | +$316K | ﹤0.01% | 2637 |
|
|
2019
Q1 | $2.36M | Sell |
67,941
-96,185
| -59% | -$2.78M | ﹤0.01% | 2559 |
|
|
2018
Q4 | $3.2M | Buy |
164,126
+62,735
| +62% | +$1.29M | ﹤0.01% | 2245 |
|
|
2018
Q3 | $2.7M | Sell |
101,391
-14,835
| -13% | -$484K | ﹤0.01% | 2501 |
|
|
2018
Q2 | $4.39M | Buy |
116,226
+77,747
| +202% | +$2.97M | ﹤0.01% | 2065 |
|
|
2018
Q1 | $1.26M | Buy |
38,479
+8,166
| +27% | +$358K | ﹤0.01% | 2895 |
|
|
2017
Q4 | $1.48M | Sell |
30,313
-8,351
| -22% | -$422K | ﹤0.01% | 2805 |
|
|
2017
Q3 | $2.09M | Buy |
38,664
+3,008
| +8% | +$177K | ﹤0.01% | 2559 |
|
|
2017
Q2 | $2M | Buy |
35,656
+3,511
| +11% | +$141K | ﹤0.01% | 2529 |
|
|
2017
Q1 | $1.26M | Buy |
32,145
+10,776
| +50% | +$343K | ﹤0.01% | 2734 |
|
|
2016
Q4 | $480K | Buy |
21,369
+11,904
| +126% | +$233K | ﹤0.01% | 3214 |
|
|
2016
Q3 | $215K | Buy |
+9,465
| New | +$222K | ﹤0.01% | 3556 |
|
|
2016
Q2 | – | Sell |
-11,528
| Closed | -$235K | – | 3979 |
|
|
2016
Q1 | $235K | Sell |
11,528
-14,613
| -56% | -$464K | ﹤0.01% | 3698 |
|
|
2015
Q4 | $1.34M | Buy |
26,141
+9,416
| +56% | +$457K | ﹤0.01% | 2548 |
|
|
2015
Q3 | $713K | Sell |
16,725
-2,747
| -14% | -$133K | ﹤0.01% | 2530 |
|
|
2015
Q2 | $887K | Buy |
19,472
+3,539
| +22% | +$142K | ﹤0.01% | 2889 |
|
|
2015
Q1 | $605K | Buy |
15,933
+405
| +3% | +$13.9K | ﹤0.01% | 3157 |
|
|
2014
Q4 | $440K | Sell |
15,528
-7,207
| -32% | -$200K | ﹤0.01% | 3340 |
|
|
2014
Q3 | $575K | Buy |
+22,735
| New | +$599K | ﹤0.01% | 3110 |
|
Parametric Portfolio Associates's PTLA Position: Q3 2020 in Review
Parametric Portfolio Associates sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 70,225 shares — an estimated $1.26M sold.
Parametric Portfolio Associates first reported a position in PTLA in Q3 2014 and held it in 23 quarters. The position peaked at $4.39M in Q2 2018. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Parametric Portfolio Associates reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Parametric Portfolio Associates sold 70,225 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.26M.
- Parametric Portfolio Associates first reported a position in Portola Pharmaceuticals, Inc. in Q3 2014 and held it in 23 quarters.
- Parametric Portfolio Associates's Portola Pharmaceuticals, Inc. position peaked at $4.39M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Parametric Portfolio Associates's 13F filing for Q3 2020, filed 12 Nov 2020.